Comprensión actual, diagnóstico, tratamiento y prevención | 16 JUL 17

Bronquiolitis, una puesta al día

La bronquiolitis es una enfermedad de gran impacto en la salud pública con una importante morbi-mortalidad en niños pequeños
Autor/a: H. Cody Meissner, M.D. N Engl J Med 2016;374:62-72.
INDICE:  1. Página 1 | 2. Página 1
Página 1

1. Hall CB, Weinberg GA, Iwane MK, et al. The burden of RSV infection in Young children. N Engl J Med 2009; 360: 588-98.

2. Stockman LJ, Curns AT, Anderson LJ, Fisher-Langley G. Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J 2012; 31: 5-9.

3. Hall CB, Weinberg GA, Blumkin AK, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months. Pediatrics 2013; 132(2): e341-e348.

4. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372: 835-45.

5. Hasegawa K, Tsugawa Y, Brown DFM, Mansbach JM, Camargo CA Jr. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics 2013; 132: 28-36.

6. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375: 1545- 55.

7. Haynes AK, Manangan AP, Iwane MK, et al. Respiratory syncytial virus circulation in seven countries with Global Disease Detection regional centers. J Infect Dis 2013; 208: Suppl 3: S246-S254.

8. Byington CL, Wilkes J, Korgenski K, Sheng X. Respiratory syncytial virus-associated mortality in hospitalized infants and young children. Pediatrics 2015; 135(1): e24-e31.

9. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134(5):e1474-e1502.

10. American Academy of Pediatrics Committee on Infectious Diseases, American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014; 134(2): e620-e638.

11. Meissner HC, Hall CB. Respiratory syncytial virus. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, eds. Feigin and Cherry’s textbook of Pediatric infectious diseases. 7th ed. Philadelphia: Elsevier Saunders, 2014: 2407-34.

12. Schroeder AR, Mansbach JM, Stevenson M, et al. Apnea in children hospitalized with bronchiolitis. Pediatrics 2013; 132(5): e1194-e1201.

13. Mansbach JM, Piedra PA, Teach SJ, et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 2012; 166: 700-6.

14. Martin ET, Fairchok MP, Stednick ZJ, Kuypers J, Englund JA. Epidemiology of multiple respiratory viruses in childcare attendees. J Infect Dis 2013; 207: 982-9.

15. Chorazy ML, Lebeck MG, McCarthy TA, Richter SS, Torner JC, Gray GC. Polymicrobial acute respiratory infections in a hospital-based pediatric population. Pediatr Infect Dis J 2013; 32: 460-6.

16. Hasegawa K, Mansbach JM, Teach SJ, et al. Multicenter study of viral etiology and relapse in hospitalized children with bronchiolitis. Pediatr Infect Dis J 2014; 33: 809-13.

17. Midulla F, Scagnolari C, Bonci E, et al. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 2010; 95: 35-41.

18. Peng D, Zhao D, Liu J, et al. Multipathogen infections in hospitalized children with acute respiratory infections. Virol J 2009; 6: 155.

19. Martin ET, Kuypers J, Wald A, Englund JA. Multiple versus single virus respiratory infections: viral load and clinical disease severity in hospitalized children. Influenza Other Respir Viruses 2012; 6: 71-7.

20. Jansen RR, Wieringa J, Koekkoek SM, et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol 2011; 49: 2631-6.

21. Self WH, Williams DJ, Zhu Y, et al. Respiratory viral infection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis 2015 July 14 (Epub ahead of print).

22. Collins PL, Melero JA. Progress in understanding and controlling RSV: still crazy after all these years. Virus Res 2011;162: 80-99.

23. IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531-7.

24. Christiaansen AF, Knudson CJ, Weiss KA, Varga SM. The CD4 T cell response to respiratory syncytial virus infection. Immunol Res 2014; 59: 109-17.

25. Welliver TP, Garofalo RP, Hosakote Y, et al. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 2007; 195: 1126-36.

26. Hasegawa K, Jartti T, Mansbach JIM, et al. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis 2015; 211: 1550-9.

27. El Saleeby CM, Bush AJ, Harrison LM, Aitken JA, DeVincenzo JP. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis 2011; 204: 996-1002.

28. Jansen RR, Schinkel J, Dek I, et al. Quantitation of respiratory viruses in relation to clinical course in children with acute respiratory tract infections. Pediatr Infect Dis J 2010; 29: 82-4.

29. Wright PF, Gruber WC, Peters M, et al. Illness severity, viral shedding and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2002; 185: 1011-8.

30. Bennett BL, Garofalo RP, Crou SG, et al. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis 2007; 195: 1532-40.

31. Chu HY, Steinhoff MC, Magaret A, et al. Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh. J Infect Dis 2014; 210: 1582-9.

32. Eick A, Karron R, Shaw J, et al. The role of neutralizing antibody in protection of American Indians against RSV disease. Pediatr Infect Dis J 2008; 27: 207-12.

33. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917-28.

34. Boyce TG, Mellen BG, Mitchel EF, et al. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000; 137: 865-70.

35. Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM. Respiratory syncytial virus and premature infants born at 32 weeks’ gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med 2000; 154: 55-61.

36. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357: 1946-55.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024